tiprankstipranks
Trending News
More News >
Alnylam Pharmaceuticals (GB:0HD2)
LSE:0HD2

Alnylam Pharma (0HD2) Revenue

Compare
4 Followers

Alnylam Pharma Revenue

Alnylam Pharma had a revenue of 1.25B in the quarter ending Sep 30, 2025, with 61.44%. This bring the company's revenue in the last twelve months to 3.21B, Decreased 30.39%. In the fiscal year ending Dec 31, 2024, Alnylam Pharma had annual revenue of 2.25B with 22.97% growth.
Revenue (ttm)
3.21B
Revenue Growth
P/S Ratio
23.54
Revenue/Employee
$1,008,181
Employees
2,230
Market Cap
$52.92B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
2.25B419.95M+122.97%
Dec 31, 2023
1.83B790.87M+176.23%
Dec 31, 2022
1.04B193.13M+122.88%
Dec 31, 2021
844.29M351.43M+171.31%
Dec 31, 2020
492.85M273.10M+224.28%
Dec 31, 2019
219.75M144.84M+293.36%
Dec 31, 2018
74.91M-15.00M+83.31%
Dec 31, 2017
89.91M42.75M+190.66%
Dec 31, 2016
47.16M